Ritter Pharmaceuticals Announces Collaboration with University of Nebraska to Explore Development of Microbiome Therapeutics in Metabolic Syndrome Biotech Investing
Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer Biotech Investing
Voyager Therapeutics Announces Updates from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease Biotech Investing
Great Basin Announces Request to Withdraw S-1 Registration Statement and Amendment to $75 Million 2016 Convertible Note Biotech Investing
Servier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing Platform Biotech Investing
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B Biotech Investing
Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology Biotech Investing
